Cargando…
Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC)
As a poor prognosis indicator in patients with pancreatic ductal adenocarcinoma (PDCA), lymph node (LN) metastasis is of great importance in treatment. Present study was performed to evaluate the predictive value of preoperative neutrophil-to-lymphocyte ratio (NLR), Platelet-to-lymphocyte ratio (PLR...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342055/ https://www.ncbi.nlm.nih.gov/pubmed/27494847 http://dx.doi.org/10.18632/oncotarget.11031 |
_version_ | 1782513093261131776 |
---|---|
author | Tao, Lianyuan Zhang, Lingfu Peng, Ying Tao, Ming Li, Gang Xiu, Dianrong Yuan, Chunhui Ma, Chaolai Jiang, Bin |
author_facet | Tao, Lianyuan Zhang, Lingfu Peng, Ying Tao, Ming Li, Gang Xiu, Dianrong Yuan, Chunhui Ma, Chaolai Jiang, Bin |
author_sort | Tao, Lianyuan |
collection | PubMed |
description | As a poor prognosis indicator in patients with pancreatic ductal adenocarcinoma (PDCA), lymph node (LN) metastasis is of great importance in treatment. Present study was performed to evaluate the predictive value of preoperative neutrophil-to-lymphocyte ratio (NLR), Platelet-to-lymphocyte ratio (PLR) and possible clinical parameters on the LN metastasis in PDCA patients. A total of 159 operable patients with PDCA were enrolled in our study. The clinical utility of NLR and other clinical parameters was evaluated by receiver operating characteristic (ROC) curves. Overall survival analysis indicated that LN metastasis is an independent prognostic factor. The logistic analysis was used to determine the independent parameters associated with LN metastasis. Ideal cutoff values for predicting LN metastasis are 2.12 for NLR and 130.96 for PLR according to the ROC curve. Multivariate analyses indicate that NLR (HR 2.588; 95% CI 1.246-5.376; P = 0.011), CA125 (HR 6.348; 95% CI 2.056-19.594; P = 0.001) and CA19-9 (HR 2.738; 95% CI 1.151-6.515; P = 0.023) are associated significantly with LN metastasis independently. Preoperative NLR, CA125 and CA19-9 are useful biomarkers for the prediction of LN metastasis in PDCA patients. |
format | Online Article Text |
id | pubmed-5342055 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53420552017-03-27 Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC) Tao, Lianyuan Zhang, Lingfu Peng, Ying Tao, Ming Li, Gang Xiu, Dianrong Yuan, Chunhui Ma, Chaolai Jiang, Bin Oncotarget Clinical Research Paper As a poor prognosis indicator in patients with pancreatic ductal adenocarcinoma (PDCA), lymph node (LN) metastasis is of great importance in treatment. Present study was performed to evaluate the predictive value of preoperative neutrophil-to-lymphocyte ratio (NLR), Platelet-to-lymphocyte ratio (PLR) and possible clinical parameters on the LN metastasis in PDCA patients. A total of 159 operable patients with PDCA were enrolled in our study. The clinical utility of NLR and other clinical parameters was evaluated by receiver operating characteristic (ROC) curves. Overall survival analysis indicated that LN metastasis is an independent prognostic factor. The logistic analysis was used to determine the independent parameters associated with LN metastasis. Ideal cutoff values for predicting LN metastasis are 2.12 for NLR and 130.96 for PLR according to the ROC curve. Multivariate analyses indicate that NLR (HR 2.588; 95% CI 1.246-5.376; P = 0.011), CA125 (HR 6.348; 95% CI 2.056-19.594; P = 0.001) and CA19-9 (HR 2.738; 95% CI 1.151-6.515; P = 0.023) are associated significantly with LN metastasis independently. Preoperative NLR, CA125 and CA19-9 are useful biomarkers for the prediction of LN metastasis in PDCA patients. Impact Journals LLC 2016-08-02 /pmc/articles/PMC5342055/ /pubmed/27494847 http://dx.doi.org/10.18632/oncotarget.11031 Text en Copyright: © 2016 Tao et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Clinical Research Paper Tao, Lianyuan Zhang, Lingfu Peng, Ying Tao, Ming Li, Gang Xiu, Dianrong Yuan, Chunhui Ma, Chaolai Jiang, Bin Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC) |
title | Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC) |
title_full | Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC) |
title_fullStr | Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC) |
title_full_unstemmed | Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC) |
title_short | Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC) |
title_sort | preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (pdac) |
topic | Clinical Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342055/ https://www.ncbi.nlm.nih.gov/pubmed/27494847 http://dx.doi.org/10.18632/oncotarget.11031 |
work_keys_str_mv | AT taolianyuan preoperativeneutrophiltolymphocyteratioandtumorrelatedfactorstopredictlymphnodemetastasisinpatientswithpancreaticductaladenocarcinomapdac AT zhanglingfu preoperativeneutrophiltolymphocyteratioandtumorrelatedfactorstopredictlymphnodemetastasisinpatientswithpancreaticductaladenocarcinomapdac AT pengying preoperativeneutrophiltolymphocyteratioandtumorrelatedfactorstopredictlymphnodemetastasisinpatientswithpancreaticductaladenocarcinomapdac AT taoming preoperativeneutrophiltolymphocyteratioandtumorrelatedfactorstopredictlymphnodemetastasisinpatientswithpancreaticductaladenocarcinomapdac AT ligang preoperativeneutrophiltolymphocyteratioandtumorrelatedfactorstopredictlymphnodemetastasisinpatientswithpancreaticductaladenocarcinomapdac AT xiudianrong preoperativeneutrophiltolymphocyteratioandtumorrelatedfactorstopredictlymphnodemetastasisinpatientswithpancreaticductaladenocarcinomapdac AT yuanchunhui preoperativeneutrophiltolymphocyteratioandtumorrelatedfactorstopredictlymphnodemetastasisinpatientswithpancreaticductaladenocarcinomapdac AT machaolai preoperativeneutrophiltolymphocyteratioandtumorrelatedfactorstopredictlymphnodemetastasisinpatientswithpancreaticductaladenocarcinomapdac AT jiangbin preoperativeneutrophiltolymphocyteratioandtumorrelatedfactorstopredictlymphnodemetastasisinpatientswithpancreaticductaladenocarcinomapdac |